Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChromaCode
Carlsbad, California, United States
- Ownership
- Private
- Employees
- ~26
- Development stage
- Other
01
Overview
ChromaCode's HDPCR™ platform enables high-plex, rapid, and cost-effective molecular diagnostics in oncology and other genomics applications, with products in use for tumor profiling and MRD, and development ongoing for disease monitoring and transplant rejection. No clinical trial results reported; product adoption focused on diagnostic labs and hospitals.
- Therapeutic areas
- OncologyHematologyImmunologyOther
- Modalities
- DeviceReagentCloud-based software
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on ChromaCode.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ChromaCode.